qvar 50 µg/dose druckgasinhalation, lösung
teva - beclometasone dipropionate - druckgasinhalation, lösung - 50 µg/dose - beclometasone dipropionate 50 µg/dose - beclometasone
qvar autohaler 50 µg/dose druckgasinhalation, lösung
teva - beclometasone dipropionate - druckgasinhalation, lösung - 50 µg/dose - beclometasone dipropionate 50 µg/dose - beclometasone
beclometasone apotex 0,05 % nasenspray, suspension
apotex - beclometasone dipropionate - nasenspray, suspension - 0,05 % - beclometasone dipropionate 50 µg/dose - beclometasone
qvar 100 µg/dose druckgasinhalation, lösung
teva - beclometasone dipropionate - druckgasinhalation, lösung - 100 µg/dose - beclometasone dipropionate 100 µg/dose - beclometasone
qvar autohaler 100 µg/dose druckgasinhalation, lösung
teva - beclometasone dipropionate - druckgasinhalation, lösung - 100 µg/dose - beclometasone dipropionate 100 µg/dose - beclometasone
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarat dihydrat, glycopyrronium bromide - lungenerkrankung, chronisch obstruktiv - medikamente für obstruktive atemwegserkrankungen, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
trydonis
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarat dihydrat, glycopyrronium - lungenerkrankung, chronisch obstruktiv - medikamente für obstruktive atemwegserkrankungen, - erhaltungstherapie bei erwachsenen patienten mit mittelschwerer bis schwerer chronisch obstruktiver lungenerkrankung (copd), die nicht ausreichend durch eine kombination von einer inhalativen kortikosteroiden und einem langwirksamen beta2-agonisten behandelt werden (für auswirkungen auf die kontrolle der symptome und vorbeugung von exazerbationen siehe abschnitt 5.
beclometasone/ formoterol cipla 200/6 mikrogramm/sprühstoß, druckgasinhalation, lösung
cipla europe - beclometasondipropionat, wasserfreies; formoterolfumarat dihydrat -
beclometasone/formoterol cipla 100/6 mikrogramm/sprühstoß, druckgasinhalation, lösung
cipla europe nv - beclometasondipropionat, wasserfreies; formoterolfumarat dihydrat -
beclophar 400 µg hartkapsel mit pulver zur inhalation
sandoz - beclometasone dipropionate - hartkapsel mit pulver zur inhalation - 400 µg - beclometasone dipropionate 400 µg - beclometasone